What does Dr. Ercan Cesmeli - Dr. Leyla Yüksel do?

Dr. Ercan Cesmeli - Dr. Leyla Yüksel is a specialist medical practice in Gent. Private Limited, started on 14 August 2013, 1 establishment.

What is the address of Dr. Ercan Cesmeli - Dr. Leyla Yüksel?

The registered office of Dr. Ercan Cesmeli - Dr. Leyla Yüksel is located at Maurice Maeterlinckstraat 12, 9000 Gent.

Is Dr. Ercan Cesmeli - Dr. Leyla Yüksel still active?

Yes. According to the CBE (2 November 2026) Dr. Ercan Cesmeli - Dr. Leyla Yüksel is active, legal situation “Normale toestand”, started on 14 August 2013.

Is Dr. Ercan Cesmeli - Dr. Leyla Yüksel registered on Peppol?

Yes, Dr. Ercan Cesmeli - Dr. Leyla Yüksel is registered on the Peppol network with ID 0208:0537651895.

What is the enterprise number of Dr. Ercan Cesmeli - Dr. Leyla Yüksel?

The enterprise number of Dr. Ercan Cesmeli - Dr. Leyla Yüksel is BE0537651895.

When was Dr. Ercan Cesmeli - Dr. Leyla Yüksel founded?

Dr. Ercan Cesmeli - Dr. Leyla Yüksel was founded on 14 August 2013.

Who are the directors of Dr. Ercan Cesmeli - Dr. Leyla Yüksel?

According to the 2025 annual accounts, the directors of Dr. Ercan Cesmeli - Dr. Leyla Yüksel are: Ercan Cesmeli, Leyla Yuksel.

Is Dr. Ercan Cesmeli - Dr. Leyla Yüksel a reliable company?

Databakkes does not pass judgement; this is what the sources say: Active according to the CBE since 14 August 2013; 5 annual accounts filed, latest fiscal year 2025; 2 directors known from the annual account.

How much profit did Dr. Ercan Cesmeli - Dr. Leyla Yüksel make in 2025?

Dr. Ercan Cesmeli - Dr. Leyla Yüksel recorded a loss after taxes of € 4,810 in financial year 2025.

What is the revenue of Dr. Ercan Cesmeli - Dr. Leyla Yüksel?

As a small company, Dr. Ercan Cesmeli - Dr. Leyla Yüksel is not required to publish revenue in its annual accounts. In financial year 2025, its added value was € 238,818.

Dr. Ercan Cesmeli - Dr. Leyla Yüksel (Private Limited)

Dossier Dr. Ercan Cesmeli - Dr. Leyla Yüksel, printed on 2 November 2026 from databakkes.be/en/0537651895/dr-ercan-cesmeli-dr-leyla-yuksel. Sources: CBE, National Bank of Belgium, Belgian Official Gazette.

Warning lights

Signals from the annual accounts, the CBE and the Official Gazette, each with its threshold and source. No score, no verdict.

Two loss years in a row NBB

Negative result in 2024 and 2025.
Tight liquidity NBB

Cash and receivables cover 35 % of short-term debt in 2025; threshold 65 %.

Financials

Financial year 2025

Dr. Ercan Cesmeli - Dr. Leyla Yüksel from Gent, company number BE0537651895, closed financial year 2025 with a result of € -4,810 after tax. For that financial year Dr. Ercan Cesmeli - Dr. Leyla Yüksel recorded a gross margin of € 238,818 and equity of € 628,467. Compared with financial year 2024, the result moved from € -10,792 to € -4,810. The company made a loss. The buffer is growing. Debts are under control. The most recent annual accounts were filed with the National Bank of Belgium on September 28, 2026.

What it is worth Growing

€ 628,467

▲ € 514,109 vs 2024

Assets minus debts, by the books. What is left if everything were sold and paid today.

Loss Caution

€ -4,810

▲ 55 % less loss than in 2024

Profit after tax over the fiscal year.

Cash in the bank

€ 323,316

▲ € 308,691 vs 2024

Cash and bank balances on the last day of the fiscal year.

Where the profit goes Caution

Loss, nothing to pay out

Reserves fell to € 591,267.

People and assets in 2025

Vehicles and equipment

€ 64,497

▲ € 50,903 vs 2024

Book value of vehicles, furniture and equipment.

Debts at end 2025

Bank debt ≈ 8 years to go The accounts give the long-term loan and the part due within the year. The remainder divided by that part is the number of years at an equal pace; a new loan or early repayment changes it.

€ 697,225

€ 84,148 is repaid this year. At this pace the long-term loan is gone in ≈ 8 years.

Owed to suppliers

€ 32,241

▲ € 31,909 vs 2024

Supplier invoices still open on the last day of the fiscal year.

Taxes and wages

€ 21,090

▲ 33% vs 2024

Taxes, VAT and social contributions still to pay.

Key figures per fiscal year Download key figures (CSV)
	2022	2023	2024	2025	Change 2024 → 2025
Gross margin	€ 418 Gross margin 2022: € 418 First fiscal year in the series	€ 14,695 Gross margin 2023: € 14,695 ▲ € 14,278 vs 2022 (€ 418) Favourable step	€ 107,370 Gross margin 2024: € 107,370 ▲ € 92,674 vs 2023 (€ 14,695) Favourable step	€ 238,818 Gross margin 2025: € 238,818 ▲ 122% vs 2024 (€ 107,370) Favourable step	▲ 122%
Profit after taxes	€ -47,958 Profit after taxes 2022: € -47,958 First fiscal year in the series	€ -47,653 Profit after taxes 2023: € -47,653 ▲ € 305 vs 2022 (€ -47,958) Favourable step	€ -10,792 Profit after taxes 2024: € -10,792 ▲ € 36,860 vs 2023 (€ -47,653) Favourable step	€ -4,810 Profit after taxes 2025: € -4,810 ▲ € 5,983 vs 2024 (€ -10,792) Favourable step	▲ € 5,983
Equity	€ 172,804 Equity 2022: € 172,804 First fiscal year in the series	€ 125,151 Equity 2023: € 125,151 ▼ 28% vs 2022 (€ 172,804) Unfavourable step	€ 114,359 Equity 2024: € 114,359 ▼ 9% vs 2023 (€ 125,151) Unfavourable step	€ 628,467 Equity 2025: € 628,467 ▲ € 514,109 vs 2024 (€ 114,359) Favourable step	▲ € 514,109
Total debts	€ 109,063 Total debts 2022: € 109,063 First fiscal year in the series	€ 662,994 Total debts 2023: € 662,994 ▲ € 553,931 vs 2022 (€ 109,063) Unfavourable step	€ 900,319 Total debts 2024: € 900,319 ▲ 36% vs 2023 (€ 662,994) Unfavourable step	€ 1,819,371 Total debts 2025: € 1,819,371 ▲ 102% vs 2024 (€ 900,319) Unfavourable step	▲ 102%
Cash	€ 9,893 Cash 2022: € 9,893 First fiscal year in the series	€ 25,491 Cash 2023: € 25,491 ▲ 158% vs 2022 (€ 9,893) Favourable step	€ 14,626 Cash 2024: € 14,626 ▼ 43% vs 2023 (€ 25,491) Unfavourable step	€ 323,316 Cash 2025: € 323,316 ▲ € 308,691 vs 2024 (€ 14,626) Favourable step	▲ € 308,691
Land & buildings	€ 2,095 Land & buildings 2022: € 2,095 First fiscal year in the series	€ 691,879 Land & buildings 2023: € 691,879 ▲ € 689,784 vs 2022 (€ 2,095) Unchanged	€ 861,803 Land & buildings 2024: € 861,803 ▲ 25% vs 2023 (€ 691,879) Unchanged	€ 1,733,316 Land & buildings 2025: € 1,733,316 ▲ 101% vs 2024 (€ 861,803) Unchanged	▲ 101%
Retained profit	€ 154,204 Retained profit 2022: € 154,204 First fiscal year in the series	€ 106,551 Retained profit 2023: € 106,551 ▼ 31% vs 2022 (€ 154,204) Unfavourable step	€ 95,759 Retained profit 2024: € 95,759 ▼ 10% vs 2023 (€ 106,551) Unfavourable step	€ 591,267 Retained profit 2025: € 591,267 ▲ € 495,509 vs 2024 (€ 95,759) Favourable step	▲ € 495,509
Dividend	€ 202,300 Dividend 2022: € 202,300 First fiscal year in the series	€ 0 Dividend 2023: € 0 ▼ 100% vs 2022 (€ 202,300) Unchanged	€ 0 Dividend 2024: € 0 Unchanged (€ 0) Unchanged	€ 0 Dividend 2025: € 0 Unchanged (€ 0) Unchanged
Bank debt	€ 36,102 Bank debt 2022: € 36,102 First fiscal year in the series	€ 0 Bank debt 2023: € 0 ▼ 100% vs 2022 (€ 36,102) Favourable step	€ 0 Bank debt 2024: € 0 Unchanged (€ 0) Unchanged	€ 697,225 Bank debt 2025: € 697,225 Unchanged (€ 0) Unfavourable step
Balance sheet total	€ 281,866 Balance sheet total 2022: € 281,866 First fiscal year in the series	€ 788,145 Balance sheet total 2023: € 788,145 ▲ 180% vs 2022 (€ 281,866) Unchanged	€ 1,014,678 Balance sheet total 2024: € 1,014,678 ▲ 29% vs 2023 (€ 788,145) Unchanged	€ 2,447,838 Balance sheet total 2025: € 2,447,838 ▲ 141% vs 2024 (€ 1,014,678) Unchanged	▲ 141%

Key figures of Dr. Ercan Cesmeli - Dr. Leyla Yüksel, fiscal years 2022 to 2025, from the annual accounts filed with the National Bank of Belgium.Next annual account (fiscal year 2026) expected before 31 July 2027.

What happened to Dr. Ercan Cesmeli - Dr. Leyla Yüksel?

What happened at Dr. Ercan Cesmeli - Dr. Leyla Yüksel in recent years, according to the Belgian Official Gazette, the CBE and the National Bank:

Sep 28, 2026 New annual accounts for financial year 2025: loss of € 4,810. filed late Source: NBB ↗
2025 Ercan Cesmeli became a director. NBB
Aug 23, 2013 New establishment in Gent. KBO
2013 Leyla Yuksel became a director. NBB
Aug 14, 2013 Start of the company according to the CBE. KBO

In short

From € 47,958 loss in 2022 to € 4,810 loss in 2025.

Paid € 20,638 in corporate taxes since 2022.

Paid out € 202,300 in dividends to the owners in total.

Original PDFs at the National Bank ↗

Management

Ercan Cesmeli Leyla Yuksel

NTGent

Dr. Ercan Cesmeli

Dr. Ercan Cesmeli - Dr. Leyla Yüksel

Wijkgezondheidscentrum De Kaai

Behind Dr. Ercan Cesmeli - Dr. Leyla Yüksel are Ercan Cesmeli and Leyla Yuksel. Ercan Cesmeli is also behind NTGent and Dr. Ercan Cesmeli. Leyla Yuksel is also behind Wijkgezondheidscentrum De Kaai.

Directors

According to the 2025 annual accounts

Ercan Cesmeli

Director

Also active at: NTGent, Dr. Ercan Cesmeli

since 2025

Leyla Yuksel

Director

Also active at: Wijkgezondheidscentrum De Kaai

since 2013

Establishments

Establishment units

Physical locations of this company

Registered office

Maurice Maeterlinckstraat 12

9000 Gent

What is an establishment unit? An establishment unit is a geographically identifiable place where activities of the enterprise are carried out.

Details

Company number: 0537.651.895
VAT number: BE 0537.651.895
Registered office: Maurice Maeterlinckstraat 12, 9000 Gent
Names & denominations: Dr. Ercan Cesmeli - Dr. Leyla Yüksel
Enterprise type: Rechtspersoon
Legal form: Private limited company
Legal situation: Normale toestand
Start date: 14 August 2013
Peppol: Active · Active since 20 Sept 2026
Activities · NACE: Activiteiten van medisch specialisten

View on CBE Public ↗ Annual accounts (NBB) ↗